NSF award 2626560 · University of Texas at Austin

Mechanobiology of Innate Immune Cell Responses to Engineered Nanoparticles

Final report due

30 April 2030

in 1,290 days · The award ends on 31 December 2029.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

Decide about an extension2 Sep 2029in 1050 days
award ending 2029-12-31 · Research.gov
This one is ours, not NSF’s.
Extension request16 Nov 2029in 1125 days
award ending 2029-12-31 · Research.gov
PAPPG 24-1: “at least 45 days prior to the end date”
No-cost extension notice21 Dec 2029in 1160 days
award ending 2029-12-31 · Research.gov
PAPPG 24-1: “at least ten calendar days prior to the end date”
Final report due30 Apr 2030in 1290 days
award ending 2029-12-31 · Research.gov
PAPPG 24-1: “no later than 120-days following the end date of the award”
Project outcomes report due30 Apr 2030in 1290 days
award ending 2029-12-31 · Research.gov
PAPPG 24-1: “no later than 120 days following the end date”
Award is closed out30 Apr 2030in 1290 days
award ending 2029-12-31 · Research.gov
PAPPG 24-1: “financially closed out 120 days after their expiration date”

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

NSF lists this award's end date as 31 December 2029.
NSF rules say the final report is due no later than 120 days after that.
So the final report is due by 30 April 2030.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number: 2626560
Period of support: 1 Jan 2027 – 31 Dec 2029
Amount: $599,514
Awardee: University of Texas at Austin, Austin, TX
Program: BMMB-Biomech & Mechanobiology, Special Initiatives
Directorate: ENG

Abstract

Biotechnology is transforming medicine through advances in cell therapies, gene delivery, vaccines, and immunomodulatory particles. However, the success of these technologies depends on a fundamental understanding of how immune cells interpret not only biochemical signals but also the physical properties of engineered materials. Antigen-presenting myeloid cells, including macrophages and dendritic cells, regulate…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.